The primary risk associated with Dengvaxia is its administration to dengue-naive individuals. Studies have indicated that individuals who have never been infected with the dengue virus and receive the vaccine may have an increased risk of severe dengue illness if they contract the virus later. Therefore, it is crucial to confirm a previous dengue infection before administering the vaccine.
